XMEX
CYDSASAA
Market cap701mUSD
Jul 09, Last price
23.90MXN
1D
2.80%
1Q
7.17%
Jan 2017
0.42%
Name
Cydsa SAB de CV
Chart & Performance
Notes
No notes on this company yet
Write a private note on this company, for your eyes only
Profile
Cydsa, S.A.B. de C.V., along with its affiliated companies, produces and sells a diverse portfolio of salt, chlorine, caustic soda, and refrigerant gases to markets spanning Mexico, the United States, Canada, Central and South America, Asia, and Europe. Its operations are organized into key segments: Salt, Chlorine and Caustic Soda, Refrigerant Gases, and Energy Processing and Logistics. The company's salt offerings range from light and flavored salts to Kosher and halal varieties, suitable for residential, culinary, and industrial uses. Within its chlorine and caustic soda division, Cydsa supplies products such as liquid and gaseous chlorine, sodium hypochlorite, and various grades of caustic soda, serving critical roles in the chemical, petrochemical, water treatment, paper, and mining industries, among others. Furthermore, it manufactures refrigerant, propellant, and blowing gases, as well as specialized gases for fluoropolymers and medical anesthetics, primarily for industrial, commercial, domestic refrigeration, appliance, and pharmaceutical applications. Beyond chemical production, Cydsa is also involved in energy generation, specifically electricity and steam cogeneration, hydrocarbons processing, and provides storage solutions, including underground and liquid petroleum gas storage services. Established in Monterrey, Mexico, in 1945, Cydsa markets its extensive product line under well-known brand names like La Fina, Cisne, Genetron, and Eco Flush.
Valuation
Title MXN in thousands, except ratios and share amounts | FY | FY | FY | FY | FY | FY | FY | FY | FY | FY |
|---|---|---|---|---|---|---|---|---|---|---|
| 2025‑12 | 2024‑12 | 2023‑12 | 2022‑12 | 2021‑12 | 2020‑12 | 2019‑12 | 2018‑12 | 2017‑12 | 2016‑12 | |
| Income | ||||||||||
Revenues | ||||||||||
Cost of revenue | ||||||||||
Unusual Expense (Income) | ||||||||||
NOPBT | ||||||||||
NOPBT Margin | ||||||||||
Operating Taxes | ||||||||||
Tax Rate | ||||||||||
NOPAT | ||||||||||
Net income | ||||||||||
Dividends | ||||||||||
Dividend yield | ||||||||||
Proceeds from repurchase of equity | ||||||||||
BB yield | ||||||||||
| Debt | ||||||||||
Debt current | ||||||||||
Long-term debt | ||||||||||
Deferred revenue | ||||||||||
Other long-term liabilities | ||||||||||
Net debt | ||||||||||
| Cash flow | ||||||||||
Cash from operating activities | ||||||||||
CAPEX | ||||||||||
Cash from investing activities | ||||||||||
Cash from financing activities | ||||||||||
FCF | ||||||||||
| Balance | ||||||||||
Cash | ||||||||||
Long term investments | ||||||||||
Excess cash | ||||||||||
Stockholders' equity | ||||||||||
Invested Capital | ||||||||||
ROIC | ||||||||||
ROCE | ||||||||||
| EV | ||||||||||
Common stock shares outstanding | ||||||||||
Price | ||||||||||
Market cap | ||||||||||
EV | ||||||||||
EBITDA | ||||||||||
EV/EBITDA | ||||||||||
Interest | ||||||||||
Interest/NOPBT | ||||||||||